Literature DB >> 18728

Methylprednisolone pulse therapy in the treatment of polyarteritis nodosa.

G H Neild, H A Lee.   

Abstract

Two cases of lung granulomata associated with "crescentic" glomerulonephritis both in a clinical setting of polyarteritis nodosa were treated with high doses of intravenous methylprednisolone ("pulse therapy") in single injections of 30 mg/kg body-weight. In the first case rapidly progressive glomerulonephritis with 100% crescents was arrested and followed by improvement of renal function from a creatinine clearance of 5 ml/min to 30 ml/min; in the second case multiple lung granulomata of 8 months' standing, unresponsive to oral steroids, disappeared 8 days after treatment with high dosage intravenous methylprednisolone. The use of "pulse therapy" with methylprednisolone is advocated, not only in such cases where arteritis is known or suspected, but also in radidly progressive glomerulonephritis associated with crescents.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 18728      PMCID: PMC2496672          DOI: 10.1136/pgmj.53.621.382

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  14 in total

1.  Human lymphocyte subpopulations. Effect of corticosteroids.

Authors:  D T Yu; P J Clements; H E Paulus; J B Peter; J Levy; E V Barnett
Journal:  J Clin Invest       Date:  1974-02       Impact factor: 14.808

2.  POLYARTERITIS AND ACUTE POST-STREPTOCOCCAL GLOMERULONEPHRITIS.

Authors:  C C FORDHAM; F H EPSTEIN; W D HUFFINES; J T HARRINGTON
Journal:  Ann Intern Med       Date:  1964-07       Impact factor: 25.391

3.  ACUTE OLIGURIC RENAL FAILURE IN ACUTE GLOMERULONEPHRITIS AND POLYARTERITIS NODOSA.

Authors:  C V HARRISON; L W LOUGHRIDGE; M D MILNE
Journal:  Q J Med       Date:  1964-01

4.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

5.  Combined immunosuppression and anticoagulation in rapidly progressive glomerulonephritis.

Authors:  C B Brown; D Wilson; D Turner; J S Cameron; C S Ogg; C Chantler; D Gill
Journal:  Lancet       Date:  1974-11-16       Impact factor: 79.321

6.  Anticoagulants in "irreversible" acute renal failure.

Authors:  P Kincaid-Smith; B M Saker; K F Fairley
Journal:  Lancet       Date:  1968-12-28       Impact factor: 79.321

7.  Circulating immunoglobulin complexes in Wegener's granulomatosis.

Authors:  S B Howell; W V Epstein
Journal:  Am J Med       Date:  1976-02       Impact factor: 4.965

8.  Association between polyarteritis and Australia antigen.

Authors:  D J Gocke; K Hsu; C Morgan; S Bombardieri; M Lockshin; C L Christian
Journal:  Lancet       Date:  1970-12-05       Impact factor: 79.321

9.  Long-term follow-up study of periarteritis nodosa.

Authors:  P P Frohnert; S G Sheps
Journal:  Am J Med       Date:  1967-07       Impact factor: 4.965

10.  The mechanism of action of a single dose of methylprednisolone on acute inflammation in vivo.

Authors:  S L Wiener; R Wiener; M Urivetzky; S Shafer; H D Isenberg; C Janov; E Meilman
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

View more
  7 in total

1.  Vasculitides throughout history and their clinical treatment today.

Authors:  Antonio Iglesias-Gamarra; Edgar Penaranda; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

2.  Combined therapy with methotrexate and prednisone in polyarteritis nodosa.

Authors:  H Tannenbaum
Journal:  Can Med Assoc J       Date:  1980-11-08       Impact factor: 8.262

3.  Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects.

Authors:  P R Lyons; P K Newman; M Saunders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

4.  A double blind controlled trial of methylprednisolone infusions in systemic lupus erythematosus using individualised outcome assessment.

Authors:  J C Edwards; M L Snaith; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

5.  Methyl prednisolone pulse therapy in the treatment of systemic lupus erythematosus.

Authors:  D A Isenberg; W J Morrow; M L Snaith
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

6.  Effects of high-dose i.v. steroid (pulse) therapy on acute serum sickness in rabbits.

Authors:  G H Neild; K Ivory; D G Williams
Journal:  Br J Exp Pathol       Date:  1982-12

7.  Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone.

Authors:  I A Williams; A D Mitchell; W Rothman; P Tallett; K Williams; P Pitt
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.